跳至主要内容
临床试验/NCT07567690
NCT07567690进行中(未招募)不适用

A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Number of participants experiencing at least one asthma exacerbation

研究概览

简要总结

This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patients with severe asthma

排除标准

  • •History of hypersensitivity reactions to biologics (anti IL5 or IL5Ra)

研究组 & 干预措施

Patients with severe asthma

结局指标

主要结局

Number of participants experiencing at least one asthma exacerbation

时间窗: 12 month

Number of participants experiencing at least one asthma exacerbation

Annualized rate of clinically significant asthma exacerbations

时间窗: 12 month

Annualized rate of clinically significant asthma exacerbations

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Noeul KANG

Principal Investigator

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验